domainvc.com
Domain Life Science Portfolio Companies | Domain Associates
http://www.domainvc.com/portfolio
3F Therapeutics, Inc. Devices to treat heart valve disorders. Acquired by ATS Medical, Inc. Acquired by Medtronic. Pursuing unique strategies to prevent drug resistance. Http:/ www.achaogen.com. Achillion Pharmaceuticals, Inc. Dedicated to bringing important new treatments to patients with infectious disease. Http:/ www.achillion.com. Acureon Pharmaceuticals, Inc. Acquire and market drugs focused on infectious diseases, transplant and ICU. Http:/ www.acureonpharma.com. Http:/ www.adynxx.com. Developing a...
ir.aldeyra.com
Press Releases | Aldeyra Therapeutics
http://ir.aldeyra.com/releases.cfm
Aug 10, 2016. Aldeyra Therapeutics Announces Second Quarter 2016 Financial Results and Provides Corporate Update. LEXINGTON, MA - (Marketwired) - 08/10/16 - Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehydes, today reported second quarter financial results and provided a corporate update. "We are extremely pleased with our progress through . Aug 9, 2016. Aug 8, 2016. LEXINGTON, MA - (Marketwired) - 08/...
ir.aldeyra.com
Stock Information | Aldeyra Therapeutics
http://ir.aldeyra.com/stockquote.cfm
3:59 PM ET on Nov 2, 2016. The stock information provided is for informational purposes only and is not intended for trading purposes. The stock information is provided by eSignal, stock charts are provided by EDGAR Online, both third party services, and Aldeyra Therapeutics does not maintain or provide information directly to this service. Stock information is delayed approximately 20 minutes. Sign up for email alerts. More in this section:. Lexington, MA 02421.
ir.aldeyra.com
Corporate Governance | Aldeyra Therapeutics
http://ir.aldeyra.com/downloads.cfm
Nominating and Corporate Governance Committee Charter. Code of Ethics and Business Conduct. More in this section:. 3:59 PM ET on Nov 2, 2016. Delayed at least 20 minutes. Lexington, MA 02421.
ir.aldeyra.com
Investment Calculator | Aldeyra Therapeutics
http://ir.aldeyra.com/calculator.cfm
Calculate Current Value and Shares Since: May 2, 2014. May 2, 2014. There are no adjustments for your investment. More in this section:. Lexington, MA 02421.
ir.aldeyra.com
SEC Filings | Aldeyra Therapeutics
http://ir.aldeyra.com/sec.cfm
All Filings (excluding Section 16). Sep 26, 2016. Sep 14, 2016. Sep 14, 2016. Sep 14, 2016. Sep 2, 2016. Aug 10, 2016. Aug 10, 2016. Aug 10, 2016. Aug 9, 2016. Jun 13, 2016. Treu, jesse i. 10 results per page. 25 results per page. 50 results per page. More in this section:. 3:59 PM ET on Nov 2, 2016. Delayed at least 20 minutes. Lexington, MA 02421.
palfreymanbiopharm.com
Clients
http://www.palfreymanbiopharm.com/clients.html
Since its inception, Palfreyman BioPharm Advisors has worked with a wide range of companies. Over the years, these have included:. Actea Ventures, GmbH. Aminex Therapeutics, Inc. Amorsa Therapeutics, Inc. Amakem Therapeutics, NV. Chemical Diversity, Inc. EnVivo (Forum) Pharmaceuticals, Inc. Jasco Pharmaceuticals, Inc. Neuron Systems, Inc. (now Aldeyra Therapeutics, Inc. Marc Pharmaceuticals, Inc. SK Life Sciences, Inc. Thrasos Therapeutics, Inc. Torrey Pines Investment, Inc.
ir.aldeyra.com
Investors | Aldeyra Therapeutics
http://ir.aldeyra.com/index.cfm
Aldeyra Therapeutics is a biotechnology company devoted to improving lives by inventing, developing and commercializing products that treat diseases thought to be related to endogenous aldehydes, a naturally occurring class of pro-inflammatory and toxic molecules. The companys lead product, NS2, is an aldehyde trap in development for ocular and systemic inflammation, as well as for Sjögren-Larsson Syndrome and Succinic Semi-Aldehyde Dehydrogenase Deficiency, two inborn errors of aldehyde metabol...Aldeyr...
SOCIAL ENGAGEMENT